| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1039095809 |
| P356 | DOI | 10.1007/S11883-014-0405-5 |
| P698 | PubMed publication ID | 24623177 |
| P50 | author | William H. Frishman | Q100303887 |
| P2093 | author name string | Daniel Glicklich | |
| P2860 | cites work | Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association | Q22306345 |
| Effectiveness of renal denervation therapy for resistant hypertension: a systematic review and meta-analysis | Q26999234 | ||
| Activation of EP4 receptors contributes to prostaglandin E2-mediated stimulation of renal sensory nerves | Q28566090 | ||
| Heart disease and stroke statistics--2012 update: a report from the American Heart Association | Q29547909 | ||
| Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human | Q29618981 | ||
| The sympathetic system and hypertension | Q33911976 | ||
| Renal sympathetic denervation and systemic hypertension. | Q34098483 | ||
| Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial | Q34150890 | ||
| Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months | Q34170734 | ||
| Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study | Q34180424 | ||
| Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial | Q34254971 | ||
| Sympathetic nerve biology in essential hypertension | Q34570397 | ||
| Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study | Q34605979 | ||
| Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research | Q34788452 | ||
| Effects of acute unilateral renal denervation in the rat | Q35194500 | ||
| Sympathectomy in the treatment of hypertension; review of 122 cases | Q35222038 | ||
| Incidence and prognosis of resistant hypertension in hypertensive patients | Q35932321 | ||
| A role for the paraventricular nucleus of the hypothalamus in the autonomic control of heart and kidney | Q35986749 | ||
| Renal denervation in moderate to severe CKD. | Q36050927 | ||
| Renal afferent nerves affect discharge rate of medullary and hypothalamic single units in the cat | Q70912396 | ||
| Innervation of the renal cortical tubules: a quantitative study | Q71416030 | ||
| The rat renal nerves during development | Q71605594 | ||
| Renal denervation does not abolish sustained baroreflex-mediated reductions in arterial pressure | Q79422658 | ||
| The influence of supradiaphragmatic splanchnicectomy on the heart in hypertension | Q79563751 | ||
| Prolonged activation of the baroreflex abolishes obesity-induced hypertension | Q80167384 | ||
| Paroxysmal hypertension due to baroreflex failure | Q80826156 | ||
| The paraventricular nucleus of the hypothalamus - a potential target for integrative treatment of autonomic dysfunction | Q81274545 | ||
| Surgical treatment of hypertension | Q82303805 | ||
| Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension | Q84264441 | ||
| US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008 | Q84300422 | ||
| Sustained acute voltage-dependent blood pressure decrease with prolonged carotid baroreflex activation in therapy-resistant hypertension | Q84447416 | ||
| Renal sympathetic denervation for hypertension | Q84552016 | ||
| Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension | Q84872882 | ||
| A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension | Q84948155 | ||
| Renal responses to long-term carotid baroreflex activation therapy in patients with drug-resistant hypertension | Q86601730 | ||
| The pathophysiological basis of carotid baroreceptor stimulation for the treatment of resistant hypertension | Q87178959 | ||
| Functional role of renal afferents | Q36395337 | ||
| Baroreflex activation for the treatment of hypertension: principles and practice. | Q36634303 | ||
| Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial. | Q37029407 | ||
| Device-based antihypertensive therapy: therapeutic modulation of the autonomic nervous system | Q37829578 | ||
| Rheos: an implantable carotid sinus stimulation device for the nonpharmacologic treatment of resistant hypertension | Q37834207 | ||
| Renal sympathetic denervation for the treatment of systemic hypertension. | Q38020314 | ||
| Electrical carotid sinus stimulation in treatment resistant arterial hypertension. | Q38059312 | ||
| Sympathetic renal denervation: hypertension beyond SYMPLICITY. | Q38127536 | ||
| Renal denervation for hypertension | Q38177482 | ||
| Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover | Q39172920 | ||
| Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial | Q39721026 | ||
| Renal nerves and hypertension: an update. | Q39829924 | ||
| Renal nerves in the pathogenesis of hypertension in experimental animals and humans | Q40152589 | ||
| Neural control of renal function | Q41336663 | ||
| Inability of dorsal spinal rhizotomy to prevent renal wrap hypertension in rats | Q41502683 | ||
| Change of tubular reabsorption of sodium and water after renal denervation in the dog. | Q41525326 | ||
| Interactions between nitric oxide and superoxide on the neural regulation of proximal fluid reabsorption in hypertensive rats. | Q42461097 | ||
| Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. | Q43184350 | ||
| Renal sympathetic-nerve ablation for uncontrolled hypertension | Q43285253 | ||
| Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study | Q43473084 | ||
| Nitric oxide modulates renal sensory nerve fibers by mechanisms related to substance P receptor activation | Q43638795 | ||
| Nitric oxide modulation of neurally induced proximal tubular fluid reabsorption in the rat. | Q43920047 | ||
| Prolonged activation of the baroreflex produces sustained hypotension. | Q44715083 | ||
| Renal sympathetic denervation using an irrigated radiofrequency ablation catheter for the management of drug-resistant hypertension | Q45208017 | ||
| Altered norepinephrine turnover in the brain of rats with chronic renal failure. | Q46182072 | ||
| Renal afferent denervation prevents hypertension in rats with chronic renal failure | Q46354302 | ||
| Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure | Q46672087 | ||
| Paraventricular nucleus is involved in the central pathway of cardiac sympathetic afferent reflex in rats | Q46748383 | ||
| Rheos Baroreflex Hypertension Therapy System to treat resistant hypertension | Q48015206 | ||
| Afferent renal inputs to paraventricular nucleus vasopressin and oxytocin neurosecretory neurons. | Q48334104 | ||
| An implantable carotid sinus stimulator for drug-resistant hypertension: surgical technique and short-term outcome from the multicenter phase II Rheos feasibility trial | Q48638544 | ||
| Renal sympathetic denervation: the jury is still out. | Q48959345 | ||
| Noninvasive renal sympathetic denervation by extracorporeal high-intensity focused ultrasound in a pre-clinical canine model | Q50244253 | ||
| Management of uncontrollable hypertension with a carotid sinus stimulation device. | Q50904991 | ||
| The future of interventional management of hypertension: threats and opportunities. | Q51383762 | ||
| The effect of graded renal nerve stimulation on renal function in the anaesthetized rabbit. | Q51849958 | ||
| Selective stimulation of renal nerves in the anesthetized dog. Effect on renin release during controlled changes in renal hemodynamics. | Q52727081 | ||
| FACTORS INFLUENCING THE CHOICE OF TREATMENT IN ESSENTIAL HYPERTENSION. SURGICAL, MEDICAL OR A COMBINATION OF BOTH. | Q53047122 | ||
| Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. | Q53933378 | ||
| Renal vascular morphology and haemodynamics in Dahl salt-sensitive rats on high salt-low potassium diet: neural and genetic influences. | Q54046509 | ||
| Effect of renal nerve stimulation on NaCl and H2O transport in Henle's loop of the rat. | Q54508900 | ||
| Renal and neurohormonal responses to increasing levels of lower body negative pressure in men | Q58745293 | ||
| Acute unilateral renal denervation in rats with extracellular volume expansion | Q67544811 | ||
| An investigation into the neural regulation of calcium excretion by the rat kidney | Q69402748 | ||
| Effect of stimulation of afferent renal nerves on plasma levels of vasopressin | Q69897319 | ||
| Proximal tubular transport and urinary excretion of sodium after renal denervation in sodium depleted rats | Q70078032 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 405 | |
| P577 | publication date | 2014-05-01 | |
| P1433 | published in | Current Atherosclerosis Reports | Q20821076 |
| P1476 | title | The role of nonpharmacologic device interventions in the management of drug-resistant hypertension | |
| P478 | volume | 16 |
Search more.